The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK.
Poonawalla, who is currently in London and had recently hinted at plans to expand vaccine production outside India, described his meetings in the UK as "excellent".
"We shall work even harder and strengthen India's fight against COVID-19," he said on Twitter.
